用于儿童CT剂量学表征的真实体模
研究基于参考年龄(新生儿、1、5、10、15岁)的50百分位体型模型,扩展构建了覆盖10至90百分位身高、3至13岁、共80个儿童参考体模,在Philips Brilliance 64 CT模拟的胸-腹-盆检查中计算器官剂量和有效剂量,并归一化到DLP后与体径拟合,发现多数器官的DLP归一化剂量与体径强相关(R²>0.95),有效剂量与体径相关性极强(R²>0.99)。
要点
- 80个儿童参考体模的器官剂量和有效剂量均归一化到DLP,并与体径呈指数函数关系。
- 大多数器官的DLP归一化剂量与体径强相关(R²>0.95),有效剂量与体径相关性极强(R²>0.99)。
- 该剂量数据库可用于检查前预测个体化剂量,并替代厂商报告的剂量类型。
核心结论
- 研究提供了80个正常体格儿童参考体模的器官剂量和有效剂量,这些数据可用于替代厂商报告的剂量类型、记录和追踪患者个体剂量,并支持检查前预测个体化剂量。
研究设计与样本
- 研究基于既往开发的代表参考年龄(新生儿、1、5、10、15岁)50百分位个体的体型模型,修改为覆盖男女两性10、25、75、90百分位身高及扩展年龄(3、8、13岁),共80个儿童参考体模;在Philips Brilliance 64 CT扫描仪模型上模拟胸-腹-盆检查计算剂量,并将个体器官剂量和有效剂量归一化到DLP后拟合为体径的函数。
诊断标准与关键数值
- DLP归一化器官剂量与体径强相关,多数器官R²>0.95。
- DLP归一化有效剂量与体径相关性极强,R²>0.99。
- 数据以指数函数拟合良好。
- 与其它研究比较,平均一致性约10%。
临床应用与阅片要点
- 作者认为该信息可用于替代厂商报告的剂量类型。
- 作者认为这些数据可用于记录和追踪个体患者剂量。
- 作者认为该综合剂量数据库有助于患者匹配及检查前预测个体化剂量。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: The estimation of organ doses and effective doses for children receiving CT examinations is of high interest. Newer, more realistic anthropomorphic body models can provide information on individual organ doses and improved estimates of effective dose.
MATERIALS AND METHODS: Previously developed body models representing 50th-percentile individuals at reference ages (newborn, 1, 5, 10 and 15 years) were modified to represent 10th, 25th, 75th and 90th height percentiles for both genders and an expanded range of ages (3, 8 and 13 years). We calculated doses for 80 pediatric reference phantoms from simulated chest-abdomen-pelvis exams on a model of a Philips Brilliance 64 CT scanner. Individual organ and effective doses were normalized to dose-length product (DLP) and fit as a function of body diameter.
RESULTS: We calculated organ and effective doses for 80 reference phantoms and plotted them against body diameter. The data were well fit with an exponential function. We found DLP-normalized organ dose to correlate strongly with body diameter (R2>0.95 for most organs). Similarly, we found a very strong correlation with body diameter for DLP-normalized effective dose (R2>0.99). Our results were compared to other studies and we found average agreement of approximately 10%.
CONCLUSION: We provide organ and effective doses for a total of 80 reference phantoms representing normal-stature children ranging in age and body size. This information will be valuable in replacing the types of vendor-reported doses available. These data will also permit the recording and tracking of individual patient doses. Moreover, this comprehensive dose database will facilitate patient matching and the ability to predict patient-individualized dose prior to examination.
引用
- Carver DE, Kost SD, Fraser ND, et al. Realistic phantoms to characterize dosimetry in pediatric CT. Pediatr Radiol. 2017. PMID: 28283725. doi:10.1007/s00247-017-3805-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。